Advancing Therapeutics, Improving Lives

Cefpodoxime 200mg + Clavulanate K+ 125mg

Sarcom Tablets

IN TREATMENT OF BACTERIAL INFECTIONS

THE DUAL POWER FOR KNOCKDOWN SUCCESS

Broad spectrum of antibacterial activity

Extremely low MIC values against common respiratory pathogens

Combination provides synergistic activity

Shows higher clinical cure and improvements in symptoms of LRTI as compared to Cefuroxime

Provides improvement in safety and efficacy parameters without compromising on the quality of cure

RTI

ABSCESS

ATHEROMA

FURUNCLE

CARBUNCLE

CELLULITIS

CRYPTOCOCCOSIS

Built on the Mentorship and Experience of the Leeford Group of Companies

WHO-GMP certified

All our products are manufactured at WHO-GMP certified facilities to ensure the highest standards of quality and safety.